Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions.
He represents public and private technology, medical device, and life sciences companies at all stages of growth, in addition to investment banks and VC and private equity firms.
Michael is consistently recognized among the top practitioners in his field by Chambers USA: America's Leading Lawyers for Business.
Michael Nordtvedt currently leads the capital markets practice at Wilson Sonsini Goodrich & Rosati and is a partner at the firm’s Seattle and Palo Alto offices, where he focuses on the representation of public and private technology, medical device, and life sciences companies through all stages of their growth, as well as investment banks and venture capital and private equity firms.
Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions. He also has considerable experience in counseling companies on complex governance, securities laws and disclosure issues. Michael frequently represents investment banks in their underwriting transactions and he also has broad transactional experience representing venture capital and private equity firms. Throughout the course of his career he has had responsibility for structuring and negotiating in excess of $40 billion in public and private financing transactions, for both companies and investment banks.
Prior to joining the firm in 2007, Michael practiced in the corporate group at Davis Polk & Wardwell in New York and Menlo Park, California. Michael also served in the United States Navy as an engineering officer aboard USS Lake Champlain (CG57), as executive and weapons officer aboard USS Monsoon (PC4), and at the Pentagon as an action officer responsible for international technology transfer issues.
Michael Nordtvedt currently leads the capital markets practice at Wilson Sonsini Goodrich & Rosati and is a partner at the firm’s Seattle and Palo Alto offices, where he focuses on the representation of public and private technology, medical device, and life sciences companies through all stages of their growth, as well as investment banks and venture capital and private equity firms.
Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions. He also has considerable experience in counseling companies on complex governance, securities laws and disclosure issues. Michael frequently represents investment banks in their underwriting transactions and he also has broad transactional experience representing venture capital and private equity firms. Throughout the course of his career he has had responsibility for structuring and negotiating in excess of $40 billion in public and private financing transactions, for both companies and investment banks.
Prior to joining the firm in 2007, Michael practiced in the corporate group at Davis Polk & Wardwell in New York and Menlo Park, California. Michael also served in the United States Navy as an engineering officer aboard USS Lake Champlain (CG57), as executive and weapons officer aboard USS Monsoon (PC4), and at the Pentagon as an action officer responsible for international technology transfer issues.
Companies represented in public offerings, private placements, mergers and acquisitions, and corporate law and governance include:
Investment banks represented in public offerings and private placements include:
Companies represented in public offerings, private placements, mergers and acquisitions, and corporate law and governance include:
Investment banks represented in public offerings and private placements include: